Cannabis use in Switzerland 2015-2045: A population survey based model

M. VOGEL ; C. NORDT ; R. BITAR ; L. BOESCH ; M. WALTER ; E. SEIFRITZ ; K. M. DURSTELER ; M. HERDENER | 2019
Dans International Journal of Drug Policy (Vol.69, July 2019) Article : Périodique

Background: Alternative cannabis regulation models are discussed and implemented worldwide. A baseline scenario under the assumption of no policy or market changes may prove useful to forecast cannabis use and treatment demand and evaluate chang[...]

Plus d'info

Ajouter à la sélection

Nouveauté

Relative risks of adverse effects across different opioid agonist treatments - A systematic review and meta-analysis

M. MEYER ; E. STRAZDINS ; A. GUESSOUM ; J. N. WESTENBERG ; C. APPENZELLER-HERZOG ; M. CATTANEO ; R. M. KRAUSZ ; K. M. DURSTELER ; U. E. LANG ; L. G. HEMKENS ; M. VOGEL | 2025
Dans Addiction (Vol.120, n°6, June 2025) Article : Périodique

BACKGROUND AND AIMS: Opioid agonist treatment (OAT) is established for opioid use disorder, but limited data on adverse effects exist. We aimed to review relative risks of adverse effects across opioid agonists. METHODS: Systematic review with [...]

Plus d'info

Ajouter à la sélection

Lien externe

Rethinking retention in treatment of opioid dependence - The eye of the beholder

M. VOGEL ; K. M. DURSTELER ; M. WALTER ; M. HERDENER ; C. NORDT | 2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique

Opioid dependence often is a chronic relapsing disorder. The evidence for medication-assisted treatment (MAT) being the treatment of first choice is unequivocal. Yet, health systems, professionals and patients often fail to offer or, respectivel[...]

Plus d'info

Ajouter à la sélection